Counting the Costs of COVID-19: Why Future Treatment Option Values Matter

@article{Kent2020CountingTC,
  title={Counting the Costs of COVID-19: Why Future Treatment Option Values Matter},
  author={Adrian Kent},
  journal={Applied Economics and Finance},
  year={2020},
  volume={7},
  pages={36}
}
  • A. Kent
  • Published 2020
  • Economics, Physics
  • Applied Economics and Finance
I critique a recent analysis (Miles, Stedman & Heald, 2020) of COVID-19 lockdown costs and benefits, focussing on the United Kingdom (UK). Miles et al. (2020) argue that the March-June UK lockdown was more costly than the benefit of lives saved, evaluated using the NICE threshold of £30000 for a quality-adjusted life year (QALY) and that the costs of a lockdown for 13 weeks from mid-June would be vastly greater than any plausible estimate of the benefits, even if easing produced a second… Expand

References

SHOWING 1-10 OF 19 REFERENCES
LIVING WITH COVID-19: BALANCING COSTS AGAINST BENEFITS IN THE FACE OF THE VIRUS
This paper analyses the costs and benefits of lockdown policies in the face of COVID-19. What matters for people is the quality and length of lives and one should measure costs and benefits in termsExpand
Dynamic interventions to control COVID-19 pandemic: a multivariate prediction modelling study comparing 16 worldwide countries
TLDR
Efficient implementation of dynamic suppression interventions confers a pragmatic option to prevent critical care overload and deaths, gain time to develop preventive and clinical measures, and reduce economic hardship globally. Expand
COVID-19 length of hospital stay: a systematic review and data synthesis
TLDR
The combined summary LoS distributions provided here can be used to model bed demands for contingency planning and then updated, with the novel method presented here, as more studies with aggregated statistics emerge outside China. Expand
Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network — United States, March–June 2020
TLDR
It is indicated that COVID-19 can result in prolonged illness even among persons with milder outpatient illness, including young adults, and effective public health messaging targeting these groups is warranted. Expand
Management of post-acute covid-19 in primary care
TLDR
The patient who has a delayed recovery from an episode of covid-19 that was managed in the community or in a standard hospital ward is referred to, which can be divided into those who may have serious sequelae and those with a non-specific clinical picture, often dominated by fatigue and breathlessness. Expand
Effect of Dexamethasone in Hospitalized Patients with COVID-19: Preliminary Report
TLDR
In patients hospitalized with COVID-19, dexamethasone reduced 28-day mortality among those receiving invasive mechanical ventilation or oxygen at randomization, but not among patients not receiving respiratory support. Expand
Pulmonary fibrosis and COVID-19: the potential role for antifibrotic therapy
TLDR
Data from previous coronavirus infections such as severe acute respiratory syndrome and Middle East respiratory syndrome, as well as emerging data from the COVID-19 pandemic, suggest there could be substantial fibrotic consequences following SARS-CoV-2 infection. Expand
Time Course of Lung Changes at Chest CT during Recovery from Coronavirus Disease 2019 (COVID-19).
TLDR
In patients recovering from coronavirus disease 2019 (without severe respiratory distress during the disease course), lung abnormalities on chest CT scans showed greatest severity approximately 10 days after initial onset of symptoms. Expand
Time Course of Lung Changes On Chest CT During Recovery From 2019 Novel Coronavirus (COVID-19) Pneumonia
TLDR
In patients recovering from COVID-19 pneumonia (without severe respiratory distress during the disease course), lung abnormalities on chest CT showed greatest severity approximately 10 days after initial onset of symptoms. Expand
Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study
TLDR
The CT findings across different timepoints throughout the COVID-19 pneumonia course were described, with rapid evolution from focal unilateral to diffuse bilateral ground-glass opacities that progressed to or co-existed with consolidations within 1–3 weeks. Expand
...
1
2
...